Native Macromolecular Heparin Proteoglycans Exocytosed From Stimulated Rat Serosal Mast Cells Strongly Inhibit Platelet-Collagen Interactions
Authors:
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (12) , 3578-3587
Abstract
Mast cells, the major source of tissue heparin, line the vascular system. On stimulation, rat serosal mast cells release soluble heparin proteoglycans (HEP-PGs) of very high molecular weight (750 000). We compared the effects of HEP-PGs and standard heparins (average molecular weights, 15 000 and 5 000) on platelet-collagen interactions in vitro. In contrast with the standard heparins, HEP-PGs completely inhibited collagen-induced platelet aggregation and serotonin release in platelet-rich plasma. The inhibition caused by HEP-PGs depended on its macromolecular structure. In flowing blood, HEP-PGs also inhibited platelet deposition on a collagen-coated surface both at low and high shear rates. Although HEP-PGs did not block glycoprotein (GP) Ia/IIa-mediated platelet adhesion, they attenuated subsequent platelet activation and aggregation, as well as fibrinogen binding to platelets after collagen stimulation. HEP-PGs did not bind to platelets but bound tightly to von Willebrand factor (vWf) and enhanced its binding to collagen. Although platelet adhesion at high shear rate and vWf binding to GP Ib after ristocetin stimulation were not markedly affected, HEP-PGs reduced thrombin-induced aggregation and vWf binding to GP IIb/IIIa. These findings imply that activation of vascular mast cells with ensuing secretion of HEP-PGs may locally attenuate the thrombogenicity of matrix collagen by inhibiting its platelet-activating capacity.Keywords
This publication has 36 references indexed in Scilit:
- Platelet-Collagen InteractionsSeminars in Thrombosis and Hemostasis, 1995
- Chromatographic Preparation of a Therapeutic Highly Purified von Willebrand Factor Concentrate from Human CryoprecipitateVox Sanguinis, 1992
- Platelet procoagulant activity: physiological significance and mechanisms of exposureBlood Reviews, 1991
- Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.Journal of Clinical Investigation, 1991
- Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetinEuropean Journal of Biochemistry, 1991
- Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentratesBritish Journal of Haematology, 1989
- In Vitro Studies of the Interaction of Heparin, Low Molecular Weight Heparin and Heparinoids with PlateletsAnnals of the New York Academy of Sciences, 1989
- Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1.Journal of Clinical Investigation, 1987
- Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagenCell, 1986
- Human blood platelets showing no response to collagen fail to express surface glycoprotein IaNature, 1985